Stroke Trial, Recruiting NCT05651945 Sponsor: Hackensack Meridian Health Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05651945
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been diagnosed with a stroke (either a blockage-type or bleeding-type stroke), confirmed by medical imaging
  • People who have been assessed by a heart specialist and cleared to take part in a cardiac rehabilitation program, with no medical reasons preventing participation based on established guidelines
  • People who are able to move on and off a recumbent (reclined) exercise bike safely, with or without a mobility aid or help from another person
  • People who are able to follow simple instructions and communicate if they are in pain or distress
  • People who have been admitted to an inpatient rehabilitation facility following their stroke
  • People who have signed a consent form agreeing to take part in the study

Who may not be able to join:

  • People who have had a specific type of brain bleed called a subarachnoid hemorrhage, or who have certain blood vessel conditions in the brain, such as an intracranial aneurysm, intracranial hemangioma, or arteriovenous malformation
  • People with other medical conditions that the lead researcher determines would prevent safe participation in the study
  • People for whom a baseline assessment cannot be completed within 60 days of their stroke diagnosis
  • People who are assessed as unlikely to be able to follow the study requirements
  • People with a known terminal illness where life expectancy is less than one year
  • People whose diagnosis makes them eligible for standard cardiac rehabilitation covered by their insurance
  • People who are unable to understand or speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sara J Cuccurullo, MD, Hackensack Meridian Health - JFK Johnson Rehabilitation Institute

Phone: 732-321-7000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hackensack Meridian Health
Registry
ClinicalTrials.gov
Start date
20 January 2023
Est. completion
20 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

6-Minute Walk Test (6MWT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov